34.
Touitou, E., Barry, B. W.:
Enhancement in Drug Delivery
, Boca Raton: CRC Press, 2010.
35.
Stromquist, N. P.:
Women in the Third World: An Encyclopedia of Contemporary Issues
, London: Routledge,
2014.
36.
Michael, A.:
Bellesiles: Lethal Imagination: Violence and Brutality in American History
, New York: NYU Press,
1999
37.
Advertisement, Accessed 5/12/2014 at http://torontoist.com/attachments/toronto_jamieb/
20100216lysol48.jpg
38.
K-Y
®
: FAQ, Accessed 5/13/2014 at http://www.k-y.ca/faq
39.
Berkley, S. F.: The relationship of tampon characteristics to menstrual toxic shock syn- drome.
JAMA
.
1987;258:917.
40.
CFR Title 21 Part 801.430 – User labeling for menstrual tampons, Last update: 1/1/2013, Accessed
5/14/2014 at http://www.accessdata.fda.gov/scripts/
cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr
=
801.430
41.
Oh, M. K., Funkhouser, E., Simpson, T., et al.: Early onset of vaginal douching is associ- ated with false beliefs
and high-risk behavior.
Sex Transm Dis.
2003;30(9):689-693.
42.
Wilson, T. E., Uusküla, A., Feldman, J., et al.: A case-control study of beliefs and behav- iors associated with
sexually transmitted disease occurrence in Estonia.
Sex Transm Dis.
2001;28(11):624-649.
43.
Cottrell, B. H.: An updated review of evidence to discourage douching.
MCN Am J Mat Child Nurs.
2010;35(2):102-107.
44.
Misra, D. P., Trabert, B.: Vaginal douching and risk of preterm birth among African Amer- ican women.
Am J
Obstet Gynecol
. 2007;196(2):140:1 – 8.
45.
Martino, J. L., Vermund, S. H.: Vaginal douching: evidence for risks or benefits to women’s health.
Epidemiol Rev.
2002;24:109 – 124.
46.
Ellington, J., Daugherty, S.: Prevalence of vaginal dryness in trying-to-conceive couples.
Fertil Steril.
2003;79(2):21 – 22.
47.
Practice Committee of American Society for Reproductive Medicine in collaboration with Society for Reproductive
Endocrinology and Infertility: Optimizing natural fertility.
Fertil Steril.
2008;90(5):Supplement 1:S1 – S6.
48.
Steiner, M., Piedrahita, C., Glover, L., et al.: The impact of lubricants on latex condoms during vaginal
intercourse.
Int J STD AIDS
. 1994;5(1):29-36.
49.
WHO: Use and Procurement of Additional Lubricants for Male and Female Condoms: WHO/UNFPA/FHI,
Accessed 5/3/2014 at http://apps.who.int/iris/
bitstream/10665/76581/1/WHO_RHR_12.34_eng.pdf
50.
Sihvo, S.: Self-medication with vaginal antifungal drugs: physicians’ experiences and women’s utilization
patterns.
Fam Pract.
2000;17(2):145 – 149.
51.
McCaig, L. F., McNeil, M. M.: Trends in prescribing for vulvovaginal candidiasis in the
United States.
Pharmacoepidemiol Drug Saf .
2005;14(2):113 – 120.
52.
Wujanto, L., Wakelin, S.: Allergic contact dermatitis to colophonium in a sanitary pad — an overlooked allergen?
Contact Dermatitis.
2012;66(3):161 – 162.
53.
Williams, J. D., Frowen, K. E., Nixon, R. L.: Allergic contact dermatitis from methyldibromo glutaronitrile in a
sanitary pad and review of Australian clinic data.
Con- tact Dermatitis.
2007;56(3):164 – 167.
54.
Schreiber, C. A., Meyn, L. A., Creinin, M. D., et al.: Effects of long-term use of nonoxynol-9 on vaginal flora.
Obstet Gynecol
. 2006;107(1):136 – 143.
55.
Fashemi, B., Delaney, M. L., Onderdonk, A. B., et al.: Effects of feminine hygiene prod- ucts on the vaginal
mucosal biome.
Microb Ecol Health D.
2013;24:19703.
537
56.
Aral, S. O., Mosher, W. D., Cates, W.: Vaginal douching among women of reproductive age in the United States:
1988.
Am J Public Health
. 1992;82(2):210 – 214.
Достарыңызбен бөлісу: |